Figure 5.
Therapeutic strategies targeting thromboinflammation and endothelial injury in COVID-19. In addition to vaccines or antiviral agents, therapeutic strategies, targeting inflammation, platelet hyperactivation, thrombosis, and endothelial dysfunction, might improve clinical outcomes, including mortality, in COVID-19 patients. ACE2, angiotensin-converting enzyme 2; BK, bradykinin; DOAC, direct oral anticoagulant; JAK, Janus kinase; MAC, membrane attack complex; NET, neutrophil extracellular trap; NO, nitric oxide; PD-1, programmed cell death protein 1.